| mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin, H Glantz, ... Science 372 (6549), 1413-1418, 2021 | 558 | 2021 |
| Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation E Seydoux, LJ Homad, AJ MacCamy, KR Parks, NK Hurlburt, ... Immunity 53 (1), 98-105. e5, 2020 | 395 | 2020 |
| Structural basis for broad coronavirus neutralization MM Sauer, MA Tortorici, YJ Park, AC Walls, L Homad, OJ Acton, ... Nature structural & molecular biology 28 (6), 478-486, 2021 | 167 | 2021 |
| Designed proteins assemble antibodies into modular nanocages R Divine, HV Dang, G Ueda, JA Fallas, I Vulovic, W Sheffler, S Saini, ... Science 372 (6537), eabd9994, 2021 | 135 | 2021 |
| Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects MF Jennewein, AJ MacCamy, NR Akins, J Feng, LJ Homad, NK Hurlburt, ... Cell reports 36 (2), 2021 | 103 | 2021 |
| Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual E Seydoux, LJ Homad, AJ MacCamy, KR Parks, NK Hurlburt, ... BioRxiv, 2020 | 61 | 2020 |
| Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit NK Hurlburt, LJ Homad, I Sinha, MF Jennewein, AJ MacCamy, YH Wan, ... Communications biology 5 (1), 342, 2022 | 54 | 2022 |
| Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1 L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin, H Glantz, ... MedRxiv, 2021.02. 05.21251182, 2021 | 42 | 2021 |
| Neutralizing antibodies protect against oral transmission of lymphocryptovirus S Singh, LJ Homad, NR Akins, CM Stoffers, S Lackhar, H Malhi, YH Wan, ... Cell Reports Medicine 1 (3), 2020 | 36 | 2020 |
| Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge H Malhi, LJ Homad, YH Wan, B Poudel, B Fiala, AJ Borst, JY Wang, ... Cell Reports Medicine 3 (6), 2022 | 27 | 2022 |
| Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies E Seydoux, YH Wan, J Feng, A Wall, S Aljedani, LJ Homad, AJ MacCamy, ... Cell reports 35 (5), 2021 | 10 | 2021 |
| Epstein-Barr Virus glycoprotein antibody titers and risk of nasopharyngeal carcinoma AE Coghill, A McGuire, S Sinha, L Homad, I Sinha, A Sholukh, WP Koh, ... Open Forum Infectious Diseases 9 (12), ofac635, 2022 | 3 | 2022 |
| A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge KR Edwards, H Malhi, K Schmidt, AR Davis, LJ Homad, NL Warner, ... npj Vaccines 9 (1), 120, 2024 | 1 | 2024 |
| Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus KR Edwards, K Schmidt, LJ Homad, GM Kher, G Xu, KA Rodrigues, ... Cell Reports Medicine 5 (6), 2024 | 1 | 2024 |
| Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.(preprint) N Hurlburt, L Homad, I Siha, MF Jenewein, A MacCamy, YH Wan, ... | | 2021 |
| Development of a novel VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies. E Seydoux, YH Wan, J Feng, A Wall, S Aljedani, LJ Homad, AJ Maccamy, ... Journal of the International AIDS Society 24 (S1), 22-23, 2021 | | 2021 |
